HEPHAISTOS-Pharma

Thanks to the WACKER team for welcoming us today in Amsterdam 🇳🇱 It was a great occasion to visit a #GMP manufacturing site and to have a technical discussion on Downstream Process #DSP development and Formulation #Scaleup 💉 HEPHAISTOS-Pharma is preparing industrialization of its manufacturing process with the aim of conducting regulatory tox studies and clinical trials in #oncology. Thanks to Ronald Eulenberger Sandra Verhaagh Jos Vergeest Eric Verhagen Michael van der Horst Dr. Santosh Vijayan Eger Boonstra Joris van der Schoor Moira Monika Schuler Rob V. Martine Caroff Alexey Novikov Simon Pico Jerome Kerzerho Capucine Phelip Anaïs DEBESSET

#TalentsCNRS, #innovation, #industriesSanté, #biotech, #deeptech, #immunologie, #cancer   Échos de Viva Technology (3) !   A l’interface de l’immunologie et de l’oncologie, la société de biotechnologie HEPHAISTOS-Pharma, présente sur le stand du CNRS - Centre national de la recherche scientifique au salon Viva Technology, est emblématique d’un partenariat particulièrement réussi entre sphère académique et monde de l’entreprise.   Créée en 2018 et dirigée par Frédéric CAROFF, la startup développe une nouvelle génération d’immunothérapies contre le cancer. L’effet de stimulation du système immunitaire lié aux endotoxines a été démontré dans divers modèles animaux et sur plusieurs modèles de tumeurs : lymphomes et ostéosarcomes. Parmi les prochaines étapes figurent l'industrialisation de la production et les études réglementaires de toxicité en vue du dépôt d’une demande d'autorisation pour réaliser un essai clinique en Europe.   Jean-Luc Moullet, Carole Chrétien, Pauline Normand, CNRS Innovation, HEPHAISTOS-Pharma, PULSALYS, Martine Caroff, Frédéric CAROFF, Simon Pico, Charles Dumontet

🚀 We are very happy to announce today that HEPHAISTOS-Pharma secured 10,3 M€ to reach clinical stage. This was officially announced during the #Meet2Win #Oncology event organized by MATWIN We want to thank our private investors #VentureCapital who support us. We are delighted to have you on board : 👉 Florian Denis from Elaia 👉 Ingrid Kelly Spillmann from xista science ventures 👉 Jerome Majoie from fondation fournier majoie pour l'innovation 👉 Frédéric Schynts from Noshaq As welll as the #BusinessAngels from Angels Santé and FBA - Femmes Business Angels Eric Chetaille who joined the SAB Thanks to our institutional financing : 👉 Bpifrance #iNov 👉 European Innovation Council and SMEs Executive Agency (EISMEA) 👉 ANR (Agence nationale de la recherche) #France2030 Thanks also to the Matwin team & coaches Lucia ROBERT Jean-Yves Bonnefoy Emmanuel Conseiller, PhD, HDR Boutaina Daher who are doing a great work at connecting investors / Biotech / Pharmas This great news could not be possible without the great work from the HEPHAISTOS-Pharma team Martine Caroff Alexey Novikov Jerome Kerzerho Simon Pico Capucine Phelip 👏 👏 👏 and our great academic partners Charles Dumontet Jean-Yves Blay Aurélie Dutour 🔬 Let's go to the clinic, patients are waiting for a cure. We are now members of the Paris Saclay Cancer Cluster (PSCC) who helps us for the next financing rounds #SeriesA. They put us in contact with great scientific expert from Gustave Roussy like Aurélien Marabelle and international experts in the network of Eric Vivier. We strongly believe in the capacity of #PSCC to gather forces against cancer in the next few years.

HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer targeting innate immunity to increase the cure rate of patients, has completed its €4.5 million seed round 🇫🇷 🔬 Elaia leads a consortium previously initiated by xista science ventures, the fondation fournier majoie pour l'innovation and Noshaq. “ELAIA has a proven track record in supporting biotech companies through to the clinic and success, and we are delighted to have them on board,” said Frédéric CAROFF, CEO and co-founder of HEPHAISTOS-Pharma. 

I will be attending to #Meet2Win Bordeaux Convention on 16-17 May 2024. I will be pleased to meet other pharma companies for building collaborations and Series A investors interested in oncology #therapeutic. 🫁🧠 Thanks to the MATWIN team for organizing this event Lucia ROBERT Stéphanie Dhont Boutaina Daher Fabrice Barlesi Jean-Yves Bonnefoy 🤝 Thanks to the investors participating to the #MATWIN Board 👉Jerome Majoie from fondation fournier majoie pour l'innovation 👉Florian Denis from Elaia They are bringing their great experience in #oncology. We will present a poster summarizing the great data obtained by the HEPHAISTOS-Pharma team Jerome Kerzerho Capucine Phelip Alexey Novikov Simon Pico Martine Caroff

Thanks to Le Parisien and the Paris Saclay Cancer Cluster (PSCC) for highlighting 3 of the #PSCC biotech companies working at making cancer treatment finally effective 💊 At HEPHAISTOS-Pharma we believe in collaboration and clusters to bring innovative drugs to the patients 🤝 Congrats to Nicolas Wolikow and Benoit Larrat, PhD doing a great job in better understanding surviving patients 🫁 and better administrating drugs in the brain 🧠 Thanks to the PSCC Team for their great help Benjamin Garel Catherine Kuttner Lucie Mondoulet Alice de Queylard Frédéric Kurt Nouzha Mohellibi And the HEPHAISTOS team Martine Caroff Jerome Kerzerho Simon Pico Capucine Phelip Alexey Novikov https://lnkd.in/epN6ru7W

Frédéric CAROFF will participate to #Meet2Win on May 16-17th in Bordeaux. You can meet Frederic during the B2B meetings, feel free to ask for a meeting on the event platform. He will participate to a round table to give a feedback on MATWIN experience and the useful advices, we got from the MATWIN coaches Jean-Yves Bonnefoy and Gilles Avenard. Thank to all the MATWIN team and board for their useful recommandations.

Frédéric CAROFF, CEO at HEPHAISTOS-Pharma participated in a roundtable titled "Why the Paris Region is the Ideal Base to Develop Your Biotech Startups" organized by Choose Paris Region and facilitated by Jeremy HERVE, Head of Innovation and Economic Development at Établissement public d'aménagement Paris-Saclay, along with Benjamin Garel, CEO at Paris Saclay Cancer Cluster (PSCC), and Chloé Leprêtre, Head of External Innovation at Servier. The discussion highlighted the importance of the ecosystem for the development of successful french Biotech companies 💊 Our CEO strongly believe in the capacity of the Paris Saclay Cancer Cluster (PSCC) in fighting cancer and gathering a unique ecosystem including infrastructure, Researchers, Clinicians, Patients, CROs, CDMOs, pharmaceutical companies, investors.   To learn more about HEPHAISTOS-Pharma and our commitment to curing hard to treat cancers and metastatic patients, please visit our website at https://lnkd.in/e4ffNCAc    #cancer #OrphanDiseases #biotech #BIOEuropeSpring #Biotech #Innovation Région Île-de-France #Startup #PSCC Martine Caroff Simon Pico Jerome Kerzerho Alexey Novikov Capucine Phelip

Our CEO, Frédéric CAROFF will be attending to #BIOEuropeSpring 2024 and speaking during a #roundtable organized by Choose Paris Region in the Exhibit Hall Stage, on Tuesday 19th at 11:30am. Meet me on March 18-20 in Barcelona, Spain 🎤 👉Open for discussions with series A investors interested in #Oncology biotech companies developing game-changing #immunotherapy platform 💊 👉Open for discussions with Pharmaceutical companies interested by #immunotherapy products able to change cold tumors into hot tumors and cure hardly accessible tumors and metastatic patients. 🫁 Paris Saclay Cancer Cluster (PSCC) Albin JEANNE Celine Voisin Benjamin Garel Lucie Mondoulet Simon Pico Martine Caroff Jerome Kerzerho Capucine Phelip https://lnkd.in/eCCc3F-N

Exciting news from the PSCC Innovation Forum! 🚀 After the pitches' session of the companies supported by the PSCC, Eric Vivier, Chairman of the PSCC, and Christian Deleuze, Chairman of the #PSCCConnect association, were delighted to announce the winners of the day!   The Jury's “Coup de Coeur” goes to HEPHAISTOS-Pharma! 🎉 The “Meilleur Espoir” award goes to Orakl Oncology! Congratulations to Frédéric CAROFF CEO of Hephaistos and Diane-Laure Pagès, COO of Orakl, for this well-deserved recognition!   Stay tuned for more updates. We will continue to promote innovation and collaboration in the fight against cancer! 💪🔬   #PSCCInnovationForum #Coupdecoeur #BestHope #startup #CancerInnovation #Congratulations